2017 Clinical Investigator Award Recipients

Dr. Genevieve Boland Genevieve Boland, MD, PhD
Massachusetts General Hospital, Division of Surgical Oncology
Proposal:  Tumor and Immune Monitoring via Exosomal Analysis in Patients on Targeted Therapy with Anti-PD1 Immunotherapy
Supported by an educational grant from Amgen

Genevieve M. Boland, MD, PhD is an Assistant Professor at Harvard Medical School and an Assistant in Surgery in the Division of Surgical Oncology at the Massachusetts General Hospital. Her primary clinical focus is on melanoma and cutaneous oncology. Dr. Boland serves on the Surgical Oncology Program Committee for the Dana Farber/Harvard Surgical Oncology Fellowship, the Harvard Surgery Research Day Committee, the Resident Advisory Committee and the MGH Executive Committee on Research Subcommittee for Research Review. Her laboratory is currently focused on characterization of molecular and immunological changes that occur during immunotherapy and the identification of circulating biomarkers of cancer. As a Broad Institute affiliate, she is establishing analytic pipelines for blood-based biomarker development in cancer to transition novel biomarkers to CLIA-based assays and to prospectively validate their use through clinical trials.

Dr. Rebecca Gladdy portraitRebecca Gladdy, MD, PhD
Lunenfeld-Tanenbaum Research Institute, Sinai Health System, University of Toronto
Proposal:  Metabolic Reprogramming in Sarcoma-Repurposing Statins as Anticancer Agents
Supported by an educational grant from Genentech

Dr. Gladdy is a Surgeon Scientist and Assistant Professor at the University of Toronto who joined the faculty in 2008 after completing a Surgical Oncology Fellowship at Memorial Sloan-Kettering Cancer Center in New York. Her independent research program at the Lunenfeld-Tanenbaum Research Institute is focused on developing functional genomics platforms to inform the development of much needed effective therapies for sarcoma patients. Her clinical expertise is in the surgical management of soft tissue sarcoma. Dr. Gladdy is a member of the Sarcoma Program, which is the Centre of Excellence for Sarcoma Care in Canada and is affiliated with Princess Margaret Cancer Centre, Mount Sinai Hospital (MSH),and the Hospital for Sick Children. In addition to having a translational research lab, she is the Director of the GI Sarcoma Clinical Research Group at MSH, which is dedicated to advancing clinical care through engaging in clinical trials and improving quality of life for sarcoma patients.